The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 17.34%. However, over the last six months, the performance has been stronger by -10.68%. The price of DNTH increased 4.88% over the last 30 days. And in the last five days, it has surged by 17.34%.
The stock market performance of Dianthus Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $33.77 on 03/22/24, while the lowest price during the same time frame was $10.65, recorded on 01/18/24.
52-week price history of DNTH Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Dianthus Therapeutics Inc’s current trading price is -24.25% away from its 52-week high, while its distance from the 52-week low is 140.19%. The stock’s price range for this period has been between $10.65 and $33.77. The Healthcare sector company’s shares saw a trading volume of about 0.23 million for the day, which was lower than the average daily volume of 0.25 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Dianthus Therapeutics Inc (DNTH) has experienced a quarterly decline of -8.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 757.09M and boasts a workforce of 53 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 26.34, with a change in price of -4.23. Similarly, Dianthus Therapeutics Inc recorded 232,317 in trading volume during the last 100 days, posting a change of -14.19%.
DNTH’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for DNTH stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
DNTH Stock Stochastic Average
As of today, the raw stochastic average of Dianthus Therapeutics Inc over the last 50 days is at 46.16%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 59.39%. Further, the company’s Stochastic %K and %D values for the last 20 days were 70.67% and 73.30%, respectively.
